Health Care News – Read More The Food and Drug Administration (FDA) has approved Novo Nordisk’s oral version of the Wegovy weight loss pill, the first such pill approved for use. Novo Nordisk said in a Tuesday release that the GLP-1 pill is intended for once-daily use to “reduce excess body weight and maintain weight reduction long-term and to reduce the…
FDA approves oral version of Wegovy
HootMD curates medical news from trusted publishers. Follow the links in this article to read the full story at the original source.
